首站-论文投稿智能助手
典型文献
Screening for a 177Lu-labeled CA19-9 monoclonal antibody via PET imaging for colorectal cancer therapy
文献摘要:
Carbohydrate antigen 19-9(CA19-9)with multi epitopes relatively high expresses on colorectal cancer(CRC)cells,making it an attractive target for developing radioimmunotherapy(RIT)for CRC.The lutetium-177(177Lu)labeled monoclonal antibodies(mAbs)can selectively bind the corresponding antigens and release targeted cytotoxic radiation,which could induce cell apoptosis and reduce the drug-induced re-sistance.Here,a series of CA19-9 mAbs were labeled with zirconium-89(89Zr),and one with high tumor uptake was screened via PET imaging,which has potential application for the diagnosis of CRC.Then the screened mAb(C003)labeled with 177Lu was utilized for CA19-9 targeted RIT,which presents a signifi-cant suppression effect on the growth of colo205 xenografts than immunotherapy alone.Meanwhile,the side effects of 177Lu-DOTA-C003 are limited according to the results of in vivo study.Both 89Zr-DFO-C003 for CRC immune-PET imaging and 177Lu-DOTA-C003 for RIT against CRC exhibit good potential in clinical applications.
文献关键词:
作者姓名:
Jing Wang;Liangang Zhuo;Peng Zhao;Wei Liao;Hongyuan Wei;Yuchuan Yang;Shuming Peng;Xia Yang
作者机构:
Institute of Nuclear Physics and Chemistry,China Academy of Engineering Physics,Mianyang 621900,China;NHC Key Laboratory of Nuclear Technology Mediccal Trasnformation(Mianyang Central Hospital),Mianyang 621900,China;Key Laboratory of Nuclear Medicine and Molecular Imaging of Sichuan Province,Mianyang 621999,China;Department of Nuclear Medicine,The Affiliated Hospital Southwest of Medical University,Luzhou 646000,China
引用格式:
[1]Jing Wang;Liangang Zhuo;Peng Zhao;Wei Liao;Hongyuan Wei;Yuchuan Yang;Shuming Peng;Xia Yang-.Screening for a 177Lu-labeled CA19-9 monoclonal antibody via PET imaging for colorectal cancer therapy)[J].中国化学快报(英文版),2022(07):3502-3506
A类:
radioimmunotherapy,C003,colo205
B类:
Screening,177Lu,labeled,CA19,monoclonal,antibody,via,PET,imaging,colorectal,cancer,Carbohydrate,multi,epitopes,relatively,high,expresses,CRC,cells,making,attractive,developing,RIT,lutetium,antibodies,mAbs,selectively,bind,corresponding,antigens,release,targeted,cytotoxic,radiation,which,could,apoptosis,reduce,drug,induced,sistance,Here,series,were,zirconium,89Zr,tumor,uptake,was,screened,has,potential,diagnosis,Then,utilized,presents,signifi,cant,suppression,growth,xenografts,than,alone,Meanwhile,side,effects,DOTA,are,limited,according,results,vivo,study,Both,DFO,immune,against,exhibit,good,clinical,applications
AB值:
0.520304
相似文献
Preparation and functional study of pH-sensitive amorphous calcium phosphate nanocarriers
Baolong Niu;Min Li;Jianhong Jia;Lixuan Ren;Xin Gang;Bin Nie;Yanying Fan;Xiaojie Lian;Wenfeng Li-College of Materials Science and Engineering,Taiyuan University of Technology,Taiyuan 030024,China;Key Laboratory of Interface Science and Engineering in Advanced Materials,Taiyuan University of Technology,Taiyuan 030024,China;School of Basic Medical Sciences,Shanxi Medical University,Taiyuan 030001,China;Department of Biomedical Engineering,Research Center for Nano-biomaterials&Regenerative Medicine,College of Biomedical Engineering,Taiyuan University of Technology,Taiyuan 030024,China;Shanxi Key Laboratory of Material Strength&Structural Impact,Institute of Biomedical Engineering,Taiyuan University of Technology,Taiyuan 030024,China
Enzyme-linked immunosorbent assays for quantification of MMMAE-conjugated ADCs and total antibodies in cynomolgus monkey sera
Min Pei;Tingting Liu;Lu Ouyang;Jianhua Sun;Xiaojie Deng;Xiaomin Sun;Wei Wu;Peng Huang;Yi-Li Chen;Xiaorong Tan;Xiaoyue Liu;Peng Zhu;Yongzhen Liu;Deheng Wang;Junliang Wu;Qi Wang;Guifeng Wang;Likun Gong;Qiuping Qin;Chunhe Wang-Biotherapeutics Discovery Research Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai,201203,China;School of Pharmacy,University of Chinese Academy of Sciences,Beijing,100049,China;Center for Drug Safety Evaluation and Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai,201203,China;Research and Development Center,Dartsbio Pharmaceuticals Ltd.,Zhongshan,Guangdong,528400,China;Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Zhongshan,Guangdong,528400,China;School of Pharmacy,Shanghai Engineering Research Center of Immunotherapeutics,Fudan University,Shanghai,201203,China
Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumors
Elena I.Shramova;Stepan P.Chumakov;Victoria O.Shipunova;Anastasiya V.Ryabova;Georgij B.Telegin;Andrei V.Kabashin;Sergey M.Deyev;Galina M.Proshkina-Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry,Russian Academy of Sciences,16/10 Miklukho-Maklaya Street,Moscow 117997,Russia;MEPhI(Moscow Engineering Physics Institute),Institute of Engineering Physics for Biomedicine(PhysBio),31 Kashirskoe shosse,Moscow 115409,Russia;Prokhorov General Physics Institute,Russian Academy of Sciences,Vavilova,38,Moscow 119991,Russia;Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry,Russian Academy of Sciences,Prospect Nauki 6,Pushchino 142290,Russia;Aix Marseille University,CNRS,LP3,163 Ave.De Luminy,Case 917,13288 Marseille,France
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
Preclinical evaluation and pilot clinical study of[18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts
Kongzhen Hu;Junqi Li;Lijuan Wang;Yong Huang;Li Li;Shimin Ye;Yanjiang Han;Shun Huang;Hubing Wu;Jin Su;Ganghua Tang-Department of Nuclear Medicine,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China;Shenzhen International Institute for Biomedical Research,Shenzhen 518116,China;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital&Shenzhen Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Shenzhen 518116,China;State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510182,China
Perfluorooctyl bromide nanoemulsions holding MnO2 nanoparticles with dual-modality imaging and glutathione depletion enhanced HIFU-eliciting tumor immunogenic cell death
Xinping Kuai;Yuefei Zhu;Zheng Yuan;Shengyu Wang;Lin Lin;Xiaodan Ye;Yiping Lu;Yu Luo;Zhiqing Pang;Daoying Geng;Bo Yin-Department of Radiology,Huashan Hospital,Fudan University,Shanghai 200040,China;School of Pharmacy,Fudan University,Key Laboratory of Smart Drug Delivery,Ministry of Education,Shanghai 201203,China;Department of Radiology,Shanghai First Maternity and Infant Hospital,Tongji University School of Medicine,Shanghai 201204,China;Department of Radiology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 201800,China;Department of Radiology,Shanghai Chest Hospital,Shanghai Jiao Tong University,Shanghai 200030,China;State Key Laboratory of High Performance Ceramics and Superfine Microstructure,School of Chemical Science and Engineering,Shanghai 200092,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。